A company focused on restoring vision using optogenetics technology.

Ray Therapeutics

Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Our studies have shown for the first time that our proprietary ChRown optogenetic protein can restore high levels of visual acuity, contrast sensitivity and visual field.

RayTx lead asset, RTx-015, is expected to address the huge unmet medical in people suffering from many forms of retinal blindness (independent of the underlying genetic cause), including those with advanced age-related macular degeneration. RayTx has partnered with a world-leading AAV gene therapy manufacturer is utilizing their proprietary commercial manufacturing process and analytics to maximally de-risk clinical development. RayTx anticipates clinical trials will begin by the end of 2023 in our initial indication, retinitis pigmentosa.

California Institute for Regenerative Medicine

California Institute of Regenerative Medicine (CIRM)

4BIO Capital

Wu Capital

MRL Ventures Fund

Deerfield

Norwest Venture Partners

Novo Holdings

Ray Therapeutics, Inc.

Our Chief Medical Officer Peter Francis, MD PhD will be speaking at the 5th Gene Therapy for Ophthalmic Disorders Summit in September 10-12 in Boston, MA. 

There will be:

Expert Speakers from across R&D, preclinical and clinical development

Interactive workshops on crucial topics spanning delivery, animal models, endpoint selection and regulatory challenges

Days of cutting edge content from AAVs and innovating vectors to confirming suitable clinical endpoints

For more information, visit: https://ter.li/xs2c2a  

Looking forward to seeing everyone there!

Our CEO Paul Bresge speaks with Raising Biotech podcast host Surani Fernando about leveraging #optogenetics to tackle #vision loss. 

Surani is also joined by renowned optogenetics leader Dr. José-Alain Sahel, Distinguished Professor, Department of Ophthalmology, University of Pittsburgh School of Medicine, to talk about Ray's scientific foundations, early data, theoretical safety/efficacy profile and potential to make a meaningful impact in late-stage retinal disorder patients with close to no vision.

Listen to the discussion:
👇👇

https://lnkd.in/efGwJP36

Join us on Saturday, May 4th at the Four Seasons Hotel Seattle for the "𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗼𝗻 𝗥𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲" moderated by world-renowned expert Dr. Mark Humayun. This session will delve into groundbreaking advancements and innovative approaches in vision restoration with highly esteemed speakers Sulagna Bhattacharya, Peter Francis, MD PhD, Ram Palanki, John Pollack, MD, and Matthias Steger PhD, MBA. Don't miss your chance to gain strategic insights and network with key players in the field. https://lnkd.in/geVddkw4

USC Roski Eye Institute
Nanoscope Therapeutics Inc.
Ray Therapeutics, Inc.
REGENXBIO Inc.
jCyte, Inc.
Endogena Therapeutics, Inc.

#OIS #OISRetina #OISRetina2024 #Ophthalmology #Innovation #RoskiEyeInstitute #Nanoscope #RayTherapeutics #REGENXBIO #jCyte #Endogena #SulagnaBhattacharya #PeterFrancis #RamPalanki #JohnPollack #MatthiasSteger

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬! The lineup of 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 for the OIS Retina Innovation Summit is here! Don't miss out on the chance to witness cutting-edge developments in retinal health and technology. 𝐑𝐞𝐬𝐞𝐫𝐯𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐭𝐨𝐝𝐚𝐲 before tickets run out! https://lnkd.in/ecAcYeV4

Annexin Pharmaceuticals AB (publ), Annexon Biosciences, Eluminex Biosciences Limited, Endogena Therapeutics, Inc., EyePoint Pharmaceuticals, FELIQS, ForwardVue Pharma, GelMEDIX, InflammX Therapeutics, Isarna Therapeutics GmbH, jCyte, Inc., Kiora Pharmaceuticals, Inc., Kriya, Nanoscope Therapeutics Inc., Neurotech Pharmaceuticals, Inc., Ocular Therapeutix, Inc., Oculis, ONL Therapeutics, Optigo Biotherapeutics, Outlook Therapeutics, Inc., RevOpsis Therapeutics, Ray Therapeutics, Inc., REGENXBIO Inc., Retinai, Ripple Therapeutics  , Stealth BioTherapeutics, Stuart Therapeutics, Tarsier Pharma

#OIS #OISRetina #Ophthalmology #Innovation #Retina #Annexin #Annexon #Eluminex #Endogena #EyePoint #FELIQS #ForwardVue #GelMEDIX #InflammX #Isarna #jCyte #Kiora #Kriya #Nanoscope #Neurotech #OcularTherapeutix #Oculis #ONLTherapeutics #OptigoBiotherapeutics #OutlookTherapeutics #RevOpsis #RayTherapeutics #REGENXBIO #Retinai #RippleTherapeutics #StealthBioTherapeutics #StuartTherapeutics #TarsierPharma

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 25, 2024 2:55 AM	36425253
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	bb80389a
crunchbase profile	general
li profile	general	Jul 25, 2024 2:55 AM	e4311867
translate crunchbase fundingrounds	general
peers	general	Jul 25, 2024 2:55 AM	4283e8dd
news basic	general	Jul 25, 2024 2:55 AM	de49ea22
bundesanzeiger	filings
financials download nd	financials
private financials	financials

RAYT

COM:RAYTHERAPEUTICS

Ray Therapeutics